{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:11:26Z","timestamp":1793146286204,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05644-5","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:42:42Z","timestamp":1784191362000},"page":"4029-4041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["METTL3-mediated N6-methyladenosine modification of circHUWE1 promotes high glucose-induced cardiomyocyte apoptosis and ferroptosis-related alterations through regulating miR-671-5p\/CELF1 axis"],"prefix":"10.1007","volume":"481","author":[{"given":"Ye","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"5644_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2021","unstructured":"Sun H et al (2021) IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"5644_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y et al (2020) Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol 17(9):585\u2013607","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"5644_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00592-013-0455-0","volume":"50","author":"E Konduracka","year":"2013","unstructured":"Konduracka E et al (2013) Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study. Acta Diabetol 50(4):597\u2013606","journal-title":"Acta Diabetol"},{"issue":"6","key":"5644_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/1479164118787415","volume":"15","author":"S Bouthoorn","year":"2018","unstructured":"Bouthoorn S et al (2018) The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis. Diab Vasc Dis Res 15(6):477\u2013493","journal-title":"Diab Vasc Dis Res"},{"issue":"4","key":"5644_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR (2018) Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res 122(4):624\u2013638","journal-title":"Circ Res"},{"issue":"4","key":"5644_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s12276-023-00958-6","volume":"55","author":"TK Pham","year":"2023","unstructured":"Pham TK et al (2023) Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db\/db mice. Exp Mol Med 55(4):767\u2013778","journal-title":"Exp Mol Med"},{"issue":"2","key":"5644_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12012-024-09836-7","volume":"24","author":"L Cai","year":"2024","unstructured":"Cai L et al (2024) Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death. Cardiovasc Toxicol 24(2):71\u201384","journal-title":"Cardiovasc Toxicol"},{"issue":"10","key":"5644_CR8","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.3390\/ijms22105094","volume":"22","author":"FF Jubaidi","year":"2021","unstructured":"Jubaidi FF et al (2021) The Potential Role of Flavonoids in Ameliorating Diabetic Cardiomyopathy via Alleviation of Cardiac Oxidative Stress, Inflammation and Apoptosis. Int J Mol Sci 22(10):5094","journal-title":"Int J Mol Sci"},{"key":"5644_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1613844","volume":"16","author":"A De","year":"2025","unstructured":"De A et al (2025) MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy. Front Pharmacol 16:1613844","journal-title":"Front Pharmacol"},{"issue":"1","key":"5644_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.amjms.2023.11.001","volume":"367","author":"Q Liu","year":"2024","unstructured":"Liu Q et al (2024) CircHDAC9 regulates myocardial ischemia-reperfusion injury via miR-671-5p\/SOX4 signaling axis. Am J Med Sci 367(1):49\u201360","journal-title":"Am J Med Sci"},{"issue":"1","key":"5644_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70094","volume":"39","author":"Z Zhang","year":"2025","unstructured":"Zhang Z et al (2025) Sevoflurane alleviates myocardial ischemia\/reperfusion injury by targeting the circ_CDR1as\/miR-671-5p\/HMGA1 axis. J Biochem Mol Toxicol 39(1):e70094","journal-title":"J Biochem Mol Toxicol"},{"key":"5644_CR12","doi-asserted-by":"publisher","first-page":"102071","DOI":"10.1016\/j.omtn.2023.102071","volume":"34","author":"A Jeong","year":"2023","unstructured":"Jeong A et al (2023) Circular RNA circSMAD4 regulates cardiac fibrosis by targeting miR-671-5p and FGFR2 in cardiac fibroblasts. Mol Ther Nucleic Acids 34:102071","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"5644_CR13","doi-asserted-by":"publisher","first-page":"E357","DOI":"10.1152\/ajpendo.00094.2024","volume":"327","author":"L Zhou","year":"2024","unstructured":"Zhou L et al (2024) Circulating exosomal circRNA-miRNA-mRNA network in a familial partial lipodystrophy type 3 family with a novel PPARG frameshift mutation c.418dup. Am J Physiol Endocrinol Metab 327(3):E357\u2013E370","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"5644_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s11658-024-00556-y","volume":"29","author":"WJ Qin","year":"2024","unstructured":"Qin WJ et al (2024) Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review. Cell Mol Biol Lett 29(1):32","journal-title":"Cell Mol Biol Lett"},{"issue":"10","key":"5644_CR15","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/CIRCRESAHA.117.311281","volume":"121","author":"KT Chang","year":"2017","unstructured":"Chang KT et al (2017) CELF1 Mediates Connexin 43 mRNA Degradation in Dilated Cardiomyopathy. Circ Res 121(10):1140\u20131152","journal-title":"Circ Res"},{"issue":"49","key":"5644_CR16","doi-asserted-by":"publisher","first-page":"35372","DOI":"10.1074\/jbc.M113.507426","volume":"288","author":"SK Verma","year":"2013","unstructured":"Verma SK et al (2013) Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling. J Biol Chem 288(49):35372\u201335386","journal-title":"J Biol Chem"},{"issue":"12","key":"5644_CR17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-020-03276-1","volume":"11","author":"G Huang","year":"2020","unstructured":"Huang G et al (2020) CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/beta-catenin pathway. Cell Death Dis 11(12):1065","journal-title":"Cell Death Dis"},{"key":"5644_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102782","volume":"64","author":"S Zhang","year":"2023","unstructured":"Zhang S et al (2023) CircRNA Galntl6 sponges miR-335 to ameliorate stress-induced hypertension through upregulating Lig3 in rostral ventrolateral medulla. Redox Biol 64:102782","journal-title":"Redox Biol"},{"key":"5644_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1665571","volume":"16","author":"Y Guan","year":"2025","unstructured":"Guan Y et al (2025) Mechanisms of circular RNAs in diabetic cardiomyopathy: biological characteristics and clinical prospects. Front Genet 16:1665571","journal-title":"Front Genet"},{"issue":"2","key":"5644_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1042\/BST20230574","volume":"52","author":"G Wei","year":"2024","unstructured":"Wei G (2024) RNA m6A modification, signals for degradation or stabilisation? Biochem Soc Trans 52(2):707\u2013717","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"5644_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.124.070279","volume":"152","author":"C Wang","year":"2025","unstructured":"Wang C et al (2025) METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy. Circulation 152(5):327\u2013345","journal-title":"Circulation"},{"issue":"1","key":"5644_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41420-023-01557-0","volume":"9","author":"J Shi","year":"2023","unstructured":"Shi J et al (2023) circRNF13, a novel N(6)-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability. Cell Death Discov 9(1):253","journal-title":"Cell Death Discov"},{"issue":"1","key":"5644_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08124-8","volume":"16","author":"Y Qian","year":"2025","unstructured":"Qian Y et al (2025) The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer. Cell Death Dis 16(1):818","journal-title":"Cell Death Dis"},{"key":"5644_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fphys.2020.00033","volume":"11","author":"SJ Wu","year":"2020","unstructured":"Wu SJ et al (2020) Dexmedetomidine Exerted Anti-arrhythmic Effects in Rat With Ischemic Cardiomyopathy via Upregulation of Connexin 43 and Reduction of Fibrosis and Inflammation. Front Physiol 11:33","journal-title":"Front Physiol"},{"issue":"5","key":"5644_CR25","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/cbdd.14324","volume":"102","author":"W Gao","year":"2023","unstructured":"Gao W et al (2023) Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in hyperlipidemic rats by inhibiting inflammation, oxidative stress and NF-kappaB. Chem Biol Drug Des 102(5):1176\u20131185","journal-title":"Chem Biol Drug Des"},{"issue":"7","key":"5644_CR26","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00210-021-02082-6","volume":"394","author":"T Sun","year":"2021","unstructured":"Sun T et al (2021) Dexmedetomidine alleviates cardiomyocyte apoptosis and cardiac dysfunction may be associated with inhibition of RhoA\/ROCK pathway in mice with myocardial infarction. Naunyn Schmiedebergs Arch Pharmacol 394(7):1569\u20131577","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5644_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00592-018-1225-9","volume":"56","author":"JE Oh","year":"2019","unstructured":"Oh JE et al (2019) Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus. Acta Diabetol 56(1):105\u2013114","journal-title":"Acta Diabetol"},{"key":"5644_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2026.03.006","volume":"249","author":"D Jia","year":"2026","unstructured":"Jia D et al (2026) WTAP-regulated m(6)A modification contributes to cuproptosis in cardiomyocytes and diabetic cardiomyopathy. Free Radic Biol Med 249:60\u201375","journal-title":"Free Radic Biol Med"},{"key":"5644_CR29","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2023.3766","author":"G He","year":"2023","unstructured":"He G et al (2023) Dexmedetomidine attenuates neuroinflammation and microglia activation in LPS-stimulated BV2 microglia cells through targeting circ-Shank3\/miR-140-3p\/TLR4 axis. Eur J Histochem. https:\/\/doi.org\/10.4081\/ejh.2023.3766","journal-title":"Eur J Histochem"},{"issue":"21","key":"5644_CR30","doi-asserted-by":"publisher","first-page":"21687","DOI":"10.18632\/aging.103975","volume":"12","author":"H Li","year":"2020","unstructured":"Li H et al (2020) Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b\/miR-27a-3p\/Dram2 pathway in a rat model of traumatic brain injury. Aging 12(21):21687\u201321705","journal-title":"Aging"},{"issue":"2","key":"5644_CR31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.advms.2024.05.002","volume":"69","author":"F Xiao","year":"2024","unstructured":"Xiao F et al (2024) Dexmedetomidine improves mitophagy and pyroptosis through the ALKBH5\/FUNDC1 axis during epidural-related maternal fever. Adv Med Sci 69(2):272\u2013280","journal-title":"Adv Med Sci"},{"key":"5644_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-026-05521-1","author":"Q Li","year":"2026","unstructured":"Li Q et al (2026) Dexmedetomidine inhibits microglia activation, neuroinflammation, and glycolysis in postoperative cognitive dysfunction by promoting YTHDF2-mediated PKM2 mRNA degradation. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-026-05521-1","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"5644_CR33","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/jat.4465","volume":"43","author":"J Lv","year":"2023","unstructured":"Lv J et al (2023) Rutaecarpine attenuates high glucose-induced damage in AC16 cardiomyocytes by suppressing the MAPK pathway. J Appl Toxicol 43(9):1306\u20131318","journal-title":"J Appl Toxicol"},{"key":"5644_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.705154","volume":"12","author":"L Dai","year":"2021","unstructured":"Dai L et al (2021) Weighted gene co-expression network analysis identifies ANGPTL4 as a key regulator in diabetic cardiomyopathy via FAK\/SIRT3\/ROS pathway in cardiomyocyte. Front Endocrinol (Lausanne) 12:705154","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5644_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13019-023-02300-7","volume":"18","author":"F Li","year":"2023","unstructured":"Li F et al (2023) Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2\/GPX4 pathway. J Cardiothorac Surg 18(1):223","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"5644_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","volume":"19","author":"M Arow","year":"2020","unstructured":"Arow M et al (2020) Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy. Cardiovasc Diabetol 19(1):7","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"5644_CR37","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41401-024-01296-7","volume":"45","author":"DN Ji","year":"2024","unstructured":"Ji DN et al (2024) CircNSD1 promotes cardiac fibrosis through targeting the miR-429-3p\/SULF1\/Wnt\/beta-catenin signaling pathway. Acta Pharmacol Sin 45(10):2092\u20132106","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"5644_CR38","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s12640-022-00523-5","volume":"40","author":"T Meng","year":"2022","unstructured":"Meng T et al (2022) Circ-HUWE1 Knockdown Alleviates Amyloid-beta-Induced Neuronal Injury in SK-N-SH Cells via miR-433-3p Release-Mediated FGF7 Downregulation. Neurotox Res 40(4):913\u2013924","journal-title":"Neurotox Res"},{"key":"5644_CR39","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.omtn.2019.12.039","volume":"19","author":"B Yue","year":"2020","unstructured":"Yue B et al (2020) The Circular RNA circHUWE1 Sponges the miR-29b-AKT3 Axis to Regulate Myoblast Development. Mol Ther Nucleic Acids 19:1086\u20131097","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"5644_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00441-021-03541-5","volume":"387","author":"X Hu","year":"2022","unstructured":"Hu X et al (2022) RNA-binding protein CELF1 promotes cardiac hypertrophy via interaction with PEBP1 in cardiomyocytes. Cell Tissue Res 387(1):111\u2013121","journal-title":"Cell Tissue Res"},{"key":"5644_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.598353","volume":"11","author":"N Lin","year":"2020","unstructured":"Lin N et al (2020) SGLT1 inhibition attenuates apoptosis in diabetic cardiomyopathy via the JNK and p38 pathway. Front Pharmacol 11:598353","journal-title":"Front Pharmacol"},{"issue":"5","key":"5644_CR42","doi-asserted-by":"publisher","first-page":"167766","DOI":"10.1016\/j.bbadis.2025.167766","volume":"1871","author":"Y Fang","year":"2025","unstructured":"Fang Y et al (2025) Cardioprotective potential of transcription factor PRRX1 silencing against myocardial ischemia\/reperfusion injury by regulating excessive mitophagy and ferroptosis through FKBP5-p38 MAPK axis. Biochim Biophys Acta Mol Basis Dis 1871(5):167766","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"5644_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpan.2024.11.001","volume":"21","author":"J Chen","year":"2024","unstructured":"Chen J, Lin A, Luo P (2024) Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies. Curr Pharm Anal 21(1):1\u201319","journal-title":"Curr Pharm Anal"},{"key":"5644_CR44","doi-asserted-by":"publisher","first-page":"ftad006","DOI":"10.1093\/femspd\/ftad006","volume":"81","author":"TT Lepcha","year":"2023","unstructured":"Lepcha TT et al (2023) Uncovering the role of microRNA671-5p\/CDCA7L\/monoamine oxidase-A signaling in Helicobacter pylori mediated apoptosis in gastric epithelial cells. Pathog Dis 81:ftad006","journal-title":"Pathog Dis"},{"issue":"4","key":"5644_CR45","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.bbrc.2018.08.126","volume":"503","author":"K Belanger","year":"2018","unstructured":"Belanger K et al (2018) CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart. Biochem Biophys Res Commun 503(4):3205\u20133211","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5644_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13471","volume":"16","author":"M Shen","year":"2024","unstructured":"Shen M et al (2024) CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR-22-3p\/DAPK2 axis. J Diabetes 16(1):e13471","journal-title":"J Diabetes"},{"issue":"2","key":"5644_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11010-021-04286-z","volume":"477","author":"J Ju","year":"2022","unstructured":"Ju J et al (2022) circRNA is a potential target for cardiovascular diseases treatment. Mol Cell Biochem 477(2):417\u2013430","journal-title":"Mol Cell Biochem"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05644-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:14:43Z","timestamp":1787908483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05644-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5644"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05644-5","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}